Belinostat loaded lipid–polymer hybrid nanoparticulate delivery system for breast cancer: improved pharmacokinetics and biodistribution in a tumor model-Reference-Cited by-同舟云学术

Belinostat loaded lipid–polymer hybrid nanoparticulate delivery system for breast cancer: improved pharmacokinetics and biodistribution in a tumor model

Published:2023 Issue:45 Volume:11 Page:10859-10872
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Pradyuth Kommera Sai¹,Salunkhe Shubham A.¹,Singh Arihant Kumar¹,Chitkara Deepak¹^ORCID,Mittal Anupama¹^ORCID

Affiliation:

1. Department of Pharmacy, Birla Institute of Technology and Science (BITS PILANI), Pilani Campus, Pilani, Rajasthan, 333031, India

Abstract

A novel lipid polymer hybrid nanoparticulate system to improve the systemic exposure of Belinostat and aid in efficient tumor uptake.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB01317K

Reference58 articles.

1. Breast cancer, https://www.who.int/news-room/fact-sheets/detail/breast-cancer , (accessed 18 November 2021)

2. S.Al-Mahmood , J.Sapiezynski , O. B.Garbuzenko and T.Minko 10.1007/s13346-018-0551-3

3. Epigenetics Underlying Susceptibility and Resilience Relating to Daily Life Stress, Work Stress, and Socioeconomic Status

4. FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Simple Method for the Preparation and Characterization of Nanostructured Lipid Carriers (NLC) Formulations for Cutaneous Use;Journal of Chemical Education;2024-09-04

2. Targeting the epigenome with advanced delivery strategies for epigenetic modulators;Bioengineering & Translational Medicine;2024-08-17

3. iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer;International Journal of Nanomedicine;2024-08

4. Emerging Trends in Hybrid Nanoparticles: Revolutionary Advances and Promising Biomedical Applications;Current Drug Metabolism;2024-05